Pharmacological treatment of patients with peripheral arterial disease (Q35091909)

6 August 2017

1 reference

title

Pharmacological treatment of patients with peripheral arterial disease (English)

1 reference

6 August 2017

Chin K Kim

1

1 reference

6 August 2017

Carsten M Schmalfuss

series ordinal

2

1 reference

6 August 2017

Richard S Schofield

series ordinal

3

1 reference

6 August 2017

David S Sheps

series ordinal

4

1 reference

6 August 2017

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

63

1 reference

6 August 2017

7

1 reference

6 August 2017

637-647

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200363070-00002

6 August 2017

0 references

cites work

Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

12 December 2020

Thrombolysis in the management of lower limb peripheral arterial occlusion--a consensus document. Working Party on Thrombolysis in the Management of Limb Ischemia

1 reference

12 December 2020

Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

The demographics of claudication and the aging of the American population

1 reference

12 December 2020

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells

1 reference

12 December 2020

Peripheral arterial disease detection, awareness, and treatment in primary care

1 reference

12 December 2020

Femoral atherosclerosis in an older British population: prevalence and risk factors

1 reference

12 December 2020

Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice.

1 reference

12 December 2020

Ticlopidine in the treatment of peripheral occlusive arterial disease

1 reference

12 December 2020

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

1 reference

12 December 2020

Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience

1 reference

12 December 2020

The effect of postoperative smoking on femoropopliteal bypass grafts

1 reference

12 December 2020

The pentoxifylline experience: exercise testing reconsidered

1 reference

12 December 2020

ABC of arterial and venous disease: vascular complications of diabetes

1 reference

12 December 2020

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial

1 reference

12 December 2020

Results of EMATAP: a double-blind placebo-controlled multicentre trial of ticlopidine in patients with peripheral arterial disease

1 reference

12 December 2020

1 reference

12 December 2020

Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

12 December 2020

The effect of warfarin on mortality and reinfarction after myocardial infarction

1 reference

12 December 2020

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

12 December 2020

Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators

1 reference

12 December 2020

Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials

1 reference

12 December 2020

Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial

1 reference

12 December 2020

beta blockade and intermittent claudication: placebo controlled trial of atenolol and nifedipine and their combination

1 reference

12 December 2020

Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study

1 reference

12 December 2020

Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty

1 reference

12 December 2020

Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators

1 reference

12 December 2020

Factors of prognostic importance for subsequent rest pain in patients with intermittent claudication

1 reference

12 December 2020

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

12 December 2020

Intermittent claudication. A risk profile from The Framingham Heart Study.

1 reference

12 December 2020

Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Scandinavian Study Group

1 reference

12 December 2020

Blood flow properties and walking performance in chronic arterial occlusive disease

1 reference

12 December 2020

Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age.

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Effect of beta-adrenergic blockers on the peripheral circulation in patients with peripheral vascular disease

1 reference

12 December 2020

The natural history of claudication: risk to life and limb.

1 reference

12 December 2020

Systolic hypertension in patients with arteriosclerosis obliterans of the lower limbs

1 reference

12 December 2020

Intermittent claudication. Incidence in the Framingham Study

1 reference

12 December 2020

Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial.

1 reference

12 December 2020

Prevalence and correlates of lower extremity arterial disease in elderly women

1 reference

12 December 2020

A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial

1 reference

12 December 2020

The prevalence of peripheral arterial disease in a defined population

1 reference

12 December 2020

Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.

1 reference

12 December 2020

Clofibrate and niacin in coronary heart disease

1 reference

12 December 2020

Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT)

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Blood pressure, stroke, and coronary heart disease

1 reference

12 December 2020

Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial disease

1 reference

12 December 2020

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

1 reference

12 December 2020

Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study

1 reference

12 December 2020

Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study

1 reference

12 December 2020

Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts

1 reference

12 December 2020

The effect of cessation of smoking on the accumulative survival rates of patients with symptomatic peripheral vascular disease.

1 reference

12 December 2020

Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial

1 reference

12 December 2020

Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery

1 reference

12 December 2020

Drug therapy: vasodilator drugs in peripheral vascular disease

1 reference

12 December 2020

The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease.

1 reference

12 December 2020

Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients

1 reference

12 December 2020

The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease

1 reference

12 December 2020

Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S)

1 reference

12 December 2020

Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease

1 reference

12 December 2020

Fate of the patient with chronic leg ischaemia. A review article

1 reference

12 December 2020

A comparison of cilostazol and pentoxifylline for treating intermittent claudication

1 reference

12 December 2020

A comparison of sustained-release bupropion and placebo for smoking cessation

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Diabetes and cardiovascular disease. The Framingham study

1 reference

12 December 2020

Update on Some Epidemiologic Features of Intermittent Claudication: The Framingham Study

1 reference

12 December 2020

Obliterative arterial disease of the lower limbs. IV. Evaluation of long-term anticoagulant therapy

1 reference

12 December 2020

Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials

1 reference

12 December 2020

Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation

1 reference

12 December 2020

Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease

1 reference

12 December 2020

Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management

1 reference

12 December 2020

Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population.

1 reference

12 December 2020

Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis

1 reference

12 December 2020

10.2165/00003495-200363070-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

6 August 2017

0 references

1 reference